Monthly versus three doses malaria chemoprophylaxis in pregnancy at Lautech Teaching Hospital Osogbo, a randomised controlled study

Not Applicable

• Conditions: Malaria; MALARIA IN PREGNANCY

• Registration Number: PACTR202304768950531
• Lead Sponsor: AYODELE KABIR ALAO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-23
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 242

Inclusion Criteria

(a)All pregnant women who consented irrespective of their age or gravidity
(b)Pregnancy at the second trimester but not more than 20weeks
(c)No history of allergic reaction to sulphonamides

Exclusion Criteria

Positive test for VDRL, diabetics, and hypertension (essential or pregnancy induced)
(b)Severe anaemia (PCV <20%)
(c)Multiple pregnancy as determined by an ultrasound scan report
(d)Other severe illness that could require hospitalization.
e)Reaction to Sulphonamides

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plavental malaria detection and ;Birth Weight and Low birth weight;Gestational Age at delivery and Preterm Births

Secondary Outcome Measures

Name	Time	Method
eonates' packed cell volume and Anaemia;Maternal Packed Cell Volume and Anaemia;Cord Blood Malaria detection;Detection and Treatment of Pregnant women for symptomatic Malaria in pregnancy